- Home
- DTST vs LSTA Comparison
DTST vs LSTA Comparison
Compare DTST & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- LSTA
- Stock Information
- Founded
- DTST 2001
- LSTA 1980
- Country
- DTST United States
- LSTA United States
- Employees
- DTST N/A
- LSTA N/A
- Industry
- DTST EDP Services
- LSTA Misc Health and Biotechnology Services
- Sector
- DTST Technology
- LSTA Health Care
- Exchange
- DTST Nasdaq
- LSTA Nasdaq
- Market Cap
- DTST 28.2M
- LSTA 20.9M
- IPO Year
- DTST N/A
- LSTA N/A
- Fundamental
- Price
- DTST $3.46
- LSTA $2.80
- Analyst Decision
- DTST
- LSTA Strong Buy
- Analyst Count
- DTST 0
- LSTA 1
- Target Price
- DTST N/A
- LSTA $15.00
- AVG Volume (30 Days)
- DTST 35.0K
- LSTA 14.5K
- Earning Date
- DTST 08-13-2025
- LSTA 08-11-2025
- Dividend Yield
- DTST N/A
- LSTA N/A
- EPS Growth
- DTST N/A
- LSTA N/A
- EPS
- DTST 0.02
- LSTA N/A
- Revenue
- DTST $25,219,312.00
- LSTA $1,000,000.00
- Revenue This Year
- DTST $12.57
- LSTA N/A
- Revenue Next Year
- DTST $9.29
- LSTA N/A
- P/E Ratio
- DTST $145.21
- LSTA N/A
- Revenue Growth
- DTST N/A
- LSTA N/A
- 52 Week Low
- DTST $2.93
- LSTA $1.87
- 52 Week High
- DTST $6.95
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- DTST 41.10
- LSTA 59.64
- Support Level
- DTST $3.34
- LSTA $2.36
- Resistance Level
- DTST $3.48
- LSTA $2.69
- Average True Range (ATR)
- DTST 0.18
- LSTA 0.22
- MACD
- DTST -0.03
- LSTA 0.02
- Stochastic Oscillator
- DTST 21.92
- LSTA 62.50
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.